tiprankstipranks
Advertisement
Advertisement
Purple Biotech reports IM1240 demonstrates potent anti-tumor activity
PremiumThe FlyPurple Biotech reports IM1240 demonstrates potent anti-tumor activity
2M ago
Purple Biotech Forms Scientific Advisory Board to Drive CAPTN-3 Tri-Specific Antibody Platform
Premium
Company Announcements
Purple Biotech Forms Scientific Advisory Board to Drive CAPTN-3 Tri-Specific Antibody Platform
2M ago
Purple Biotech Taps Converge Bio’s AI to Turbocharge Tri-Specific Antibody Platform
Premium
Company Announcements
Purple Biotech Taps Converge Bio’s AI to Turbocharge Tri-Specific Antibody Platform
3M ago
Purple Biotech regains compliance with Nasdaq
PremiumThe FlyPurple Biotech regains compliance with Nasdaq
3M ago
Purple Biotech Regains Nasdaq Compliance on Minimum Bid Price
Premium
Company Announcements
Purple Biotech Regains Nasdaq Compliance on Minimum Bid Price
3M ago
Purple Biotech price target lowered to $30 from $34 at H.C. Wainwright
Premium
The Fly
Purple Biotech price target lowered to $30 from $34 at H.C. Wainwright
3M ago
Purple Biotech trading halted, news pending
PremiumThe FlyPurple Biotech trading halted, news pending
3M ago
Purple Biotech to implement ADS ratio change
Premium
The Fly
Purple Biotech to implement ADS ratio change
4M ago
Purple Biotech to Implement ADS Ratio Change to Regain Nasdaq Bid-Price Compliance
Premium
Company Announcements
Purple Biotech to Implement ADS Ratio Change to Regain Nasdaq Bid-Price Compliance
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100